Malcolm S. Reid

2.9k total citations
44 papers, 2.3k citations indexed

About

Malcolm S. Reid is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Malcolm S. Reid has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Malcolm S. Reid's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Neuroscience and Neuropharmacology Research (12 papers) and Substance Abuse Treatment and Outcomes (12 papers). Malcolm S. Reid is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Neuroscience and Neuropharmacology Research (12 papers) and Substance Abuse Treatment and Outcomes (12 papers). Malcolm S. Reid collaborates with scholars based in United States, Sweden and India. Malcolm S. Reid's co-authors include S. Paul Berger, Kang Hsu, Mario Herrera‐Marschitz, Seiji Nishino, Urban Ungerstedt, John Rotrosen, Lars Terenius, Douglas Ziedonis, Emmanuel Mignot and Frank Flammino and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Neuropsychopharmacology.

In The Last Decade

Malcolm S. Reid

43 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malcolm S. Reid United States 27 1.2k 739 528 448 400 44 2.3k
Francesco Leri Canada 26 1.4k 1.1× 454 0.6× 456 0.9× 662 1.5× 342 0.9× 103 2.5k
Richard De La Garza United States 39 2.0k 1.6× 777 1.1× 423 0.8× 677 1.5× 343 0.9× 143 4.1k
Steven D. LaRowe United States 27 872 0.7× 417 0.6× 209 0.4× 534 1.2× 410 1.0× 46 2.2k
Ann Ho United States 39 2.8k 2.2× 1.7k 2.3× 364 0.7× 451 1.0× 715 1.8× 112 4.3k
Justin J. Anker United States 27 1.3k 1.0× 467 0.6× 232 0.4× 285 0.6× 234 0.6× 51 2.3k
Alison Oliveto United States 28 1.1k 0.9× 331 0.4× 614 1.2× 336 0.8× 272 0.7× 103 2.5k
Survjit Cheeta United Kingdom 25 1.0k 0.8× 805 1.1× 168 0.3× 309 0.7× 292 0.7× 42 2.1k
Charles A. Haertzen United States 27 1.2k 1.0× 453 0.6× 613 1.2× 338 0.8× 274 0.7× 78 2.8k
Lon R. Hays United States 28 1.2k 0.9× 233 0.3× 436 0.8× 470 1.0× 133 0.3× 88 2.3k
David Nutt United Kingdom 29 1.3k 1.1× 758 1.0× 168 0.3× 480 1.1× 219 0.5× 72 2.5k

Countries citing papers authored by Malcolm S. Reid

Since Specialization
Citations

This map shows the geographic impact of Malcolm S. Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm S. Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm S. Reid more than expected).

Fields of papers citing papers by Malcolm S. Reid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malcolm S. Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm S. Reid. The network helps show where Malcolm S. Reid may publish in the future.

Co-authorship network of co-authors of Malcolm S. Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Malcolm S. Reid. A scholar is included among the top collaborators of Malcolm S. Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malcolm S. Reid. Malcolm S. Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonne, Susan C., et al.. (2010). The Relationship between Depression and Smoking Cessation Outcomes in Treatment‐Seeking Substance Abusers. American Journal on Addictions. 19(2). 111–118. 30 indexed citations
2.
Anderson, A., Malcolm S. Reid, Tyson H. Holmes, et al.. (2009). Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104(1-2). 133–139. 175 indexed citations
3.
Hammarberg, Anders, Ingrid Nylander, Qin Zhou, et al.. (2009). The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin. Brain Research. 1305. S2–S6. 12 indexed citations
4.
Hammarberg, Anders, Nitya Jayaram‐Lindström, Olof Beck, Johan Franck, & Malcolm S. Reid. (2009). The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial. Psychopharmacology. 205(1). 53–62. 46 indexed citations
5.
Reid, Malcolm S., et al.. (2009). Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. Drug and Alcohol Dependence. 102(1-3). 144–150. 19 indexed citations
6.
Newton, Thomas F., Malcolm S. Reid, Richard De La Garza, et al.. (2008). Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology. 11(8). 1037–1037. 47 indexed citations
7.
Reid, Malcolm S., Susan C. Sonne, Edward V. Nunes, et al.. (2007). Implementation of a Smoking Cessation Treatment Study at Substance Abuse Rehabilitation Programs: Smoking Behavior and Treatment Feasibility Across Varied Community-based Outpatient Programs. Journal of Addiction Medicine. 1(3). 154–160. 17 indexed citations
8.
Reid, Malcolm S., Susan C. Sonne, Frank Flammino, et al.. (2007). Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment. 35(1). 68–77. 102 indexed citations
9.
Kampman, Kyle M., Deborah B. Leiderman, Tyson H. Holmes, et al.. (2005). Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned. Addiction. 100(s1). 102–110. 18 indexed citations
10.
Reid, Malcolm S., Paul Casadonte, Sherryl Baker, et al.. (2005). A placebo‐controlled screening trial of olanzapine, valproate, and coenzyme Q10/L‐carnitine for the treatment of cocaine dependence. Addiction. 100(s1). 43–57. 38 indexed citations
11.
Reid, Malcolm S., Burt Angrist, Sherryl Baker, et al.. (2005). A placebo‐controlled screening trial of celecoxib for the treatment of cocaine dependence. Addiction. 100(s1). 32–42. 12 indexed citations
12.
Elkashef, Ahmed, Tyson H. Holmes, D. Blöch, et al.. (2005). Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. Addiction. 100(s1). 91–101. 29 indexed citations
13.
Amass, Leslie, Walter Ling, Thomas E. Freese, et al.. (2004). Bringing Buprenorphine‐Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. American Journal on Addictions. 13(S1). S42–66. 125 indexed citations
14.
Reid, Malcolm S., Kang Hsu, Bryan K. Tolliver, et al.. (2002). Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization. Pharmacology Biochemistry and Behavior. 71(1-2). 37–54. 18 indexed citations
15.
Reid, Malcolm S., Seiji Nishino, Mehdi Tafti, et al.. (1998). Neuropharmacological Characterization of Basal Forebrain Cholinergic Stimulated Cataplexy in Narcoleptic Canines. Experimental Neurology. 151(1). 89–104. 29 indexed citations
16.
Reid, Malcolm S., et al.. (1996). Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. Brain Research. 733(1). 83–100. 57 indexed citations
17.
Reid, Malcolm S., et al.. (1996). Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport. 7(7). 1325–1329. 151 indexed citations
18.
19.
Herrera‐Marschitz, Mario, Lars Terenius, Tsukasa Sakurada, Malcolm S. Reid, & Urban Ungerstedt. (1990). The substance P(1–7) fragment is a potent modulator of substance P actions in the brain. Brain Research. 521(1-2). 316–320. 39 indexed citations
20.
Reid, Malcolm S., Mario Herrera‐Marschitz, Tomas Hökfelt, Lars Terenius, & Urban Ungerstedt. (1988). Differential modulation of striatal dopamine release by intranigral injection of γ-aminobutyric acid (GABA), dynorphin A and substance P. European Journal of Pharmacology. 147(3). 411–420. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Leri Breakdown of academic impact, for papers by Richard De La Garza Breakdown of academic impact, for papers by Steven D. LaRowe Breakdown of academic impact, for papers by Ann Ho Breakdown of academic impact, for papers by Justin J. Anker Breakdown of academic impact, for papers by Alison Oliveto Breakdown of academic impact, for papers by Survjit Cheeta Breakdown of academic impact, for papers by Charles A. Haertzen Breakdown of academic impact, for papers by Lon R. Hays Breakdown of academic impact, for papers by David Nutt
Rankless by CCL
2026